Clinical and Experimental Endocrinology, Unit for Multidisciplinary Research in Biomedicine, Instituto de Ciências Biomédicas Abel Salazar, University of Porto, Portugal; Centre for Obesity Research, University College London, London, United Kingdom; University College London Hospitals Bariatric Centre for Weight Management and Metabolic Surgery, London, United Kingdom.
Centre for Obesity Research, University College London, London, United Kingdom; University College London Hospitals Bariatric Centre for Weight Management and Metabolic Surgery, London, United Kingdom; National Institute of Health Research University College London Hospitals Biomedical Research Centre, London, United Kingdom.
Gastroenterology. 2017 May;152(7):1707-1717.e2. doi: 10.1053/j.gastro.2017.01.053. Epub 2017 Feb 11.
The gastrointestinal tract, the key interface between ingested nutrients and the body, plays a critical role in regulating energy homeostasis. Gut-derived signals convey information regarding incoming nutrients to the brain, initiating changes in eating behavior and energy expenditure, to maintain energy balance. Here we review hormonal, neural, and nutrient signals emanating from the gastrointestinal tract and evidence for their role in controlling feeding behavior. Mechanistic studies that have utilized pharmacologic and/or transgenic approaches targeting an individual hormone/mediator have yielded somewhat disappointing body weight changes, often leading to the hormone/mediator in question being dismissed as a potential obesity therapy. However, the recent finding of sustained weight reduction in response to systemic administration of a long-acting analog of the gut-hormone glucagon-like peptide-1 highlights the therapeutic potential of gut-derived signals acting via nonphysiologic mechanisms. Thus, we also review therapeutics strategies being utilized or developed to leverage gastrointestinal signals in order to treat obesity.
胃肠道是摄入的营养物质与身体之间的关键界面,在调节能量平衡方面起着至关重要的作用。肠道来源的信号将有关摄入营养物质的信息传递给大脑,从而改变进食行为和能量消耗,以维持能量平衡。在这里,我们综述了源自胃肠道的激素、神经和营养信号及其在控制进食行为中的作用的证据。利用针对单个激素/介质的药理学和/或转基因方法进行的机制研究,产生了令人有些失望的体重变化,这往往导致所研究的激素/介质被排除作为潜在的肥胖治疗方法。然而,最近发现长效胰高血糖素样肽-1类似物的全身给药可持续减轻体重,这突出了通过非生理机制作用的肠道来源信号的治疗潜力。因此,我们还综述了正在利用或开发的治疗策略,以利用胃肠道信号来治疗肥胖症。